-
Exisulind (tentative
trade name Aptosyn) is an
antineoplastic agent. It acts by
inhibiting the
enzyme cyclic guanosine monophosphate phosphodiesterase...
- are
potential inhibitors of
aldose reductase.
Other ARIs:
Risarestat Exisulind Govorestat: CNS-penetrant ARI Caficrestat: AT001 AT003
Diabetic cataract...
-
sarcoma –
exatecan mesylate –
excision –
excisional biopsy –
exemestane –
exisulind –
exocrine pancreas cell –
expanded access trial – extensive-stage small...
-
several countries.
Additional reductase inhibitors such as Alrestatin,
Exisulind, Imirestat, Zopolrestat, Tolrestat, Zenarestat, Caficrestat, Fidarestat...
- research, such as cyclo-oxygenase-2 inhibitors, the
apoptosis promoter exisulind,
proteasome inhibitors, bexarotene, the
epidermal growth factor receptor...
